Accentia Biopharmaceutical (ABPI)

All Comments on ABPI

  • commenter
    User 155044
    Sep 30 10:33 AM
    Cancer Stocks Plunge Following ASCO Meeting [view article]
    EXCELLENT JOB, Reply
  • commenter
    User 54481
    Sep 24 08:10 AM
    Accentia Biopharmaceutical's Multiple Sclerosis Breakthrough [view article]
    Where are we now with ABPI??? Reply
  • commenter
    knowledgeban
    c
    Aug 24 12:52 AM
    Insider Tip: Biodelivery Sciences Chairman Owns Accentia Biopharmaceutical [view article]
    BDSI is a buy... Aug. 29 will validate my assumptions.


    On Aug 18 10:31 AM mr. ouch wrote:

    > It is about time in my opinion that the Hopkins group in a non direct
    > way, even though of all the acquisition's it has, Accentia is the
    > one started, built and designed by the Hopkins Group themselves.
    > to see also the need for another quick form of Fentanyl realized
    > other than the 'lollipop' is well needed and not so well documented
    > or I believe known outside of the companies involved, want to be
    > involves or certain people who I know are long awaiting for alternative
    > forms of Fentanyl infusion into the body, either really quick or
    > real moderate. The FDA recently having problems with 2 or 3 of the
    > reservoir type patches, leaving only one type generic left. Which
    > too me and I am in the 50% on this don't believe it'd effectiveness
    > equals the reservoir type, which is still not that wonderful.
    >
    >
    > this is an exciting mixture of drugs, companies, brilliance and expertise
    > and to see what comes out of it should be interesting
    >
    > Staples
    >
    >
    > check out the website for a different view, sort of!     Reply
  • commenter
    Billy
    Staples
    Aug 18 10:31 AM
    My Website
    Insider Tip: Biodelivery Sciences Chairman Owns Accentia Biopharmaceutical [view article]
    It is about time in my opinion that the Hopkins group in a non direct way, even though of all the acquisition's it has, Accentia is the one started, built and designed by the Hopkins Group themselves. to see also the need for another quick form of Fentanyl realized other than the 'lollipop' is well needed and not so well documented or I believe known outside of the companies involved, want to be involves or certain people who I know are long awaiting for alternative forms of Fentanyl infusion into the body, either really quick or real moderate. The FDA recently having problems with 2 or 3 of the reservoir type patches, leaving only one type generic left. Which too me and I am in the 50% on this don't believe it'd effectiveness equals the reservoir type, which is still not that wonderful.

    this is an exciting mixture of drugs, companies, brilliance and expertise and to see what comes out of it should be interesting

    Staples


    check out the website for a different view, sort of!     Reply
  • commenter
    Olboy2
    Aug 13 02:56 PM
    Cancer Stocks on the Go: Winners and Losers [view article]
    I agree with paviov, However I would like to know about the new developments the phase II and III studies that are going well, where is the advancement taking place, how close to a cure, what company has the potential winning drug ?? Reply
  • commenter
    intaicheong
    Jun 26 09:54 AM
    Accentia Biopharmaceutical's Multiple Sclerosis Breakthrough [view article]
    abpi is a good speculative company because sinus drug should be successful eventually the reason of which is that chronic sinusitis is due to underlying chronic fungus infection that is impossible to get rid of. I hope the company understands it and try to prove their sinus drug at least control the fungus infection enouph to improve the symtom of sinustis to the very significant benefit to the patients' wellbeing. Reply
  • commenter
    bluesmoke
    Jun 19 10:20 AM
    Accentia Biopharmaceutical's Multiple Sclerosis Breakthrough [view article]
    This is major news, significant not only for MS, but up to 80 other auto-immune diseases, including Crohn's and RA. My take is this therapy could revolutionize the medical world as we know it. Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:21 AM
    My Website
    General Discussion on ABPI
    Is this a buy or a sell? Reply
  • commenter
    Alan
    Brochstein
    Mar 24 09:25 PM
    My Website
    Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things [view article]
    Sorry, Fred, but ABPI is dead... Reply
  • commenter
    bsrichard
    Mar 06 03:32 PM
    Cancer Stocks Hammered Once Again [view article]
    Alan,

    What are your thoughts on Chemokine Therapeutics Corp (CHKT)?

    And Meridian Co LTD (MRDAF)?
    Reply
  • commenter
    bsrichard
    Mar 06 11:48 AM
    Cancer Stocks Hammered Once Again [view article]
    please ignore the comment above. it was posted in the wrong thread.
    Reply
  • commenter
    bsrichard
    Mar 06 11:47 AM
    Cancer Stocks Hammered Once Again [view article]
    Maybe BofA should by this one too.

    Which bank took the highly rated debt at a discount from TMA?     Reply
  • commenter
    Alan
    Brochstein
    Mar 05 07:06 PM
    My Website
    Cancer Stocks Hammered Once Again [view article]
    I don't know the company, but it sure looks interesting. Technically, it would be nice to hold 1.75. The company is seemingly deficient in cash - it would appear that there will be either an equity or debt offering this year. If they become profitable as forecast this year, the stock could get some attention - diagnostics have been hot. Reply
  • commenter
    bsrichard
    Mar 05 12:23 PM
    Cancer Stocks Hammered Once Again [view article]
    Hi Alan,
    What is your current opinion on Clarient (CLRT)?
    Thanks very much,
    Don     Reply
  • commenter
    gino
    Aug 15 01:06 PM
    Tiny Accentia Biopharmaceuticals May Be On Its Way To Big Things [view article]
    Thats's $8.75 per share or $7,700,000.00 ! Reply
Loading...
Symbols:
Authors:
Quick Links: